ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2019 American Transplant Congress

June 1-5, 2019 in Boston, MA

View by Title View Sessions
View by Date
Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z
  • Earlier Transplant Education as CKD Progresses? CKD 3-5 Patients and Providers Weigh In

    A. D. Waterman1, O. N. Ranasinghe1, A. F. Lipsey2, C. S. Anderson1, A. Alem3, C. Bozzolo4, B. Dub3, S. L. Henry3, B. Mittman3

  • Early Achievement of Sustained Virological Response in Liver Transplant Recipients with Hepatitis C Reduces Risks of End Stage Renal Disease

    M. Yoshikawa1, T. Fukumoto2

  • Early Allograft Dysfunction Does Not Predict Graft or Patient Survival in Recipients of Living Donor Liver Transplantation

    H. J. Braun, J. L. Dodge, J. D. Grab, N. L. Ascher, J. P. Roberts

  • Early Allograft Dysfunction in High Acuity Liver Transplant Recipients

    T. Ito, M. Lu, A. Murray, D. S. Graham, J. DiNorcia, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

  • Early Allograft Dysfunction in the Setting of Histologic Ischemia Reperfusion Injury Following Liver Transplantation: Analysis of Predictors and Outcomes

    T. Ito, J. Aziz, V. G. Agopian, S. Younan, J. DiNorcia, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

  • Early And Late Borderline Lesions Exhibit Differential Outcomes In Renal Transplant Recipients

    N. K. Wilson1, S. Tremblay1, P. Lee1, S. Bumb1, R. R. Alloway1, A. R. Shields2, M. Cardi2, E. S. Woodle1

  • Early Cognitive Improvement One Month after Liver Transplant Measured by the NIH Toolbox

    M. Kim1, J. D. Peipert2, K. J. Reid1, E. M. Liotta1, M. B. Maas1, D. R. Ganger3, P. C. Zee1, D. P. Ladner4

  • Early Conversion to Belatacept in High Risk Renal Transplant Recipients

    A. Santeusanio, A. Bhansali, R. Shapiro, V. Delaney, S. Florman, G. De Boccardo

  • Early CXCR5+PD1+ICOS+ Circulating Follicular T Helpers Are Associated with De Novo Donor-Specific Anti-HLA Antibodies after Renal Transplantation

    R. Danger1, M. Chesneau1, F. Delbos2, S. Lebot1, C. Kerleau1, A. Chenouard1, A. Cesbron2, M. Giral3, S. Brouard3

  • Early Diagnosis of BK Virus Nephropathy Can Retrieve Kidney Allografts by Simple Reduction in Immunosuppressive Agents

    N. Iwahara, D. Iwami, K. Hotta, H. Okada, N. Shinohara

  • Early Impact of the New United Network for Organ Sharing Simultaneous Liver-Kidney Transplantation Allocation Policy: Improved Standardization but Similar Utilization

    G. Cullaro1, E. C. Verna2, J. C. Lai1

  • Early Outcomes Comparing Two Steroid-Avoidance Protocols in Pediatric Renal Transplantation

    D. Puliyanda1, H. Pizzo1, N. Rodig2, M. Somers2

  • Early Pancreas Loss in Simultaneous Pancreas Kidney Transplants: Does It Matter for the Kidney?

    D. Das, J. Huskey, R. Heilman, K. S. Reddy, A. Moss, J. Harbell, C. Jadlowiec

  • Early Post-transplant Weight Gain In Inner-city Kidney Transplant Recipients (ktrs) Does Not Remit And Is Associated With Poor Food Quality, Stress And Anxiety.

    A. Myrie, J. Leong, J. Fazli, Y. Akivis, C. Wilson, M. Markell

  • Early Readmission After Renal Transplant As A Valuable Quality Measure

    S. Kim1, A. Osband1, B. Merhi2, G. Bayliss2, R. Gohh2, P. Morrissey1

  • Early Rejection Outcomes with IL-2 vs. ATG Induction among Kidney Transplant Recipients Induction Differences with Early Steroid Withdrawal

    C. Burelli, A. Szczepanik, K. Yadav, E. Sanchez, M. Debroy, V. Humphreville, J. Rabets, A. Padiyar, N. Sarabu, A. Jittirat, A. Palanisamy, K. Chavin

  • Early Renal Allograft Failure after Simultaneous Liver-Kidney Transplantation: Evidence for Utilization of the Safety Net

    G. Cullaro1, E. C. Verna2, B. J. Orandi3, J. C. Lai1

  • Early Steroid Withdrawal in African American Deceased Donor Renal Transplant Recipients with Alemtuzumab Induction: Is Graft Loss on the Horizon?

    R. Lynn, B. Ravichandran, T. Sparkes, A. Haririan, J. Bromberg, J. Casale

  • Early T Cell Infiltration is Modulated by PD-1/PD-L1 Interactions in Kidney Graft

    Y. Shim, R. Fan, N. Dvorina, W. Baldwin

  • Early Tacrolimus Trough Attainment in De Novo Kidney Transplant Recipients Treated with LCP-Tacrolimus (LCPT) vs. Immediate-Release Tacrolimus (IR-Tac)

    K. Budde1, S. Bunnapradist2, S. J. Patel3, D. R. Stevens3, U. Meier-Kriesche3, B. Suwelack4

  • Early Tacrolimus Trough Concentration Variability Could Predict Rejection in Pediatric Liver Transplantation: A Single-Center and Retrospective Research

    G. Gu, Q. Xia

  • Early Use of Everolimus Plus Reduced Tacrolimus vs Standard Tacrolimus in De Novo Livertransplant Recipients: 12 Months Efficacy and Safety Data from HEPHAISTOS Study

    B. Nashan1, P. Schemmer1, H. Schlitt1, A. Pascher1, C. Klein1, U. Neumann1, I. Kroeger2, P. Wimmer2, F. Braun1

  • Early Everolimus Conversion For Renal Protection In Liver Transplantation: The Sooner The Better?

    M. Tomeczkowicz, N. Sulejmani, A. Jantz, B. Summers, T. Larson, R. Salgia

  • EBV Latent Proteins Encode for Peptides That Prevent Natural Killer Cell Inhibition

    B. Mbiribindi1, J. K. Pena1, O. Hatton2, C. Romero Moreno1, C. O. Esquivel1, O. M. Martinez1, S. M. Krams1

  • EBV Viremia and Development of EBV Specific Cytotoxic T-cells in Pediatric Renal Transplant Recipients

    H. Pizzo, D. Puliyanda, B. Shin, M. Toyoda, S. Jordan

  • EBV+ PTLD in the Modern Immunosuppression Era: Role of EBV Serology and DNAemia-Preliminary Data from CTOT-C06

    O. M. Martinez1, S. M. Krams1, M. A. Robien2, M. Lapasaran1, S. D. Boyd1, B. Armstrong3, C. Twist4, K. Weinberg1, D. Gratzinger1, B. Tan1, M. Sever3, D. Ikle3, M. Brown2, D. Bernstein1, C. O. Esquivel1

  • EBV+ PTLD Cell Lines Secrete Exosomes Containing microRNAs That Alter Immune Responses

    S. Syed, E. Maloney, A. Hui, O. Martinez, S. Krams

  • ECDI-Treated Donor Leukocytes in Primate Cardiac Allograft Recipients

    Z. Alikhassy Habibabady1, T. Zhang2, W. Sun2, X. Cheng2, L. Burdorf1, I. Tatarov2, S. Sendil2, I. Behroozfard2, B. Cerel1, D. Parsell2, R. N. Pierson III1, X. Luo3, A. M. Azimzadeh1

  • Economic Evaluation of Kidney Transplantation in the Elderly Stratified by Donor Quality

    M. Kadatz1, S. Klarenbach2, J. S. Gill1, J. Gill1

  • Economic Impact of Donor Hepatitis C Kidney Transplantation: A Medicare Cost Analysis

    K. Lentine1, M. Schnitzler2, T. Alhamad3, H. Xiao2, H. Randall2, J. Wellen2, B. Kasiske4, G. Hess5, D. Axelrod6

  • Eculizumab Deposition in Renal Transplants

    D. WANG1, S. H. Nasr1, A. B. Farris2, C. A. Schinstock3, M. P. Alexander1, L. D. Cornell1

  • Eculizumab in Kidney Transplant Recipients with Atypical Hemolytic Uremic Syndrome – Single Center Experience

    A. Bhalla, S. Alasfar, N. Alachkar

  • Effect of ATG on Monocytic Myeloid-Derived Suppressor Cells and Its Associated Mechanisms in Kidney Transplantation Recipients

    Y. Jiang, X. Zhang

  • Effect of Chronic Kidney Disease on Allo-Immune Response in Mice

    P. D. Winterberg1, H. Li1, M. E. Wagener2, M. L. Ford2

  • Effect of DSA-Free Heart Allocation on Children

    M. Skeans1, J. Pyke1, K. Audette1, R. White2, W. Mahle3, A. Savage4, J. Smith5

  • Effect of Enoxaparin Prophylaxis on Early VTE Post Lung Transplant

    S. Marshall1, K. Tsveybel1, S. Boukedes1, P. Burkett2, R. Chepuri2, A. Coppolino3, M. Divo2, S. El-Chemaly2, S. Keller2, J. Kennedy2, H. Mallidi3, G. Mody3, T. Thaniyavarn2, A. Trindade2, K. Townsend1, H. Goldberg2

  • Effect of Everolimus on IgM and IgG Memory B Cell Growth and Survival In Vitro and Applications for Effective Administration in Clinical Practice

    Y. Matsuda

  • Effect of Everolimus with Reduced-Exposure Tacrolimus and Early Steroid Elimination in Pediatric Kidney Transplant Recipients: 36-Month Outcomes from the CRADLE Study

    H. Tedesco Silva1, R. Ettenger1, A. Bjerre1, M. Christian1, L. Dello Strologo1, S. D. Marks1, L. Pape1, P. Lopez2, M. Cousin2, P. Pandey2, B. Rauer2, M. Meier2, B. Tönshoff1

  • Effect of HLA Mismatch on Recurrence and Graft Loss in Living versus Deceased Kidney Transplant Recipients with IgA Nephropathy

    T. Ishaque, F. A. Ammary, K. Jackson, D. L. Segev, A. B. Massie

  • Effect of Human Leukocytic Antigen Matching on Clinical Outcomes after Deceased Donor Renal Allograft Transplant: A Single Centre Experience

    M. E. Gramlick1, M. K. Heer2, S. Yausis2, P. R. Trevillian2

  • Effect of Induction Therapy on Absolute CD4 Count and CD4 Percentage in HIV Positive Kidney Transplant Recipients

    S. A. Kuten1, I. E. Dunne1, A. E. Cantwell1, M. J. Hobeika2, S. G. Yi2, W. Musick1, R. J. Knight2, A. O. Gaber2

  • Effect of Induction Therapy on Outcomes of De Novo Renal Transplant Recipients Receiving Everolimus with Reduced-Dose Calcineurin Inhibitor: 24-Month Results from the TRANSFORM Study

    R. Oberbauer1, F. Vincenti1, O. Viklicky1, U. Huynh-Do1, D. Kim1, J. M. Cruzado1, Y. Qazi1, M. S. Kim1, P. Narvekar2, M. P. Hernandez Gutierrez2, P. Bernhardt2, D. Kuypers1

  • Effect of Influenza Vaccine in Patients with Kidney Transplant during 2017/2018

    K. Tsujimura1, M. Ota1, H. Ishida2, K. Tanabe2

  • Effect of Paricalcitol on Markers of Inflammation in De Novo Renal Transplant Recipients

    H. K. Pihlstrøm1, T. Ueland2, A. E. Michelsen2, G. Mjøen1, K. Midtvedt1, H. Holdaas1

  • Effect of Race and Antibody-Mediated Injury on Outcomes after Early Subclinical Inflammation

    E. P. Kasik, M. E. Seifert, M. Bernard, G. Agarwal, H. Fatima, R. Gaston, B. Julian, C. Kew, V. Kumar, S. Mehta, S. Ong, F. Rosenblum, G. Towns, R. B. Mannon

  • Effect of Renal Function on Asymmetric Dimethylarginine (ADMA) Homeostasis in Kidney Donors and Recipients

    M. Y. Said1, R. M. Douwes1, M. van Londen1, I. Minović1, A. Frenay2, M. H. de Borst1, E. van den Berg1, M. R. Heiner-Fokkema3, A. A. Kayacelebi4, A. Bollenbach4, H. van Goor5, G. J. Navis1, D. Tsikas4, S. J. Bakker1

  • Effect of Severe Diarrhea on Kidney Transplant Outcomes

    J. Kim, J. Ha, Y. Kim, S. Han

  • Effectiveness Of Percutaneous Embolization As Treatment Compared To Nephrectomy For Renal Graft Intolerance Syndrome In Late Graft Failure Patients

    S. Kwon, J. Go, S. Park, S. Yoon, J. Kim, I. Moon

  • Effectiveness Of The Vittal Viability Criteria During Ex Situ Normothermic Machine Perfusion To Discriminate Hepatobiliary Organ Injury And Investigation Of Biochemical Markers For Post-transplant Complications

    Y. L. Boteon, R. Laing, J. Attard, L. Wallace, A. Smith, M. Perera, D. Mirza, H. Mergental, S. Afford

  • Effects of Co-Morbidities on Kidney Transplantation Outcome in South Korea: A Nationwide-Population Based Study

    M. Yu1, S. Park2, J. Moon2, J. Jeong2, J. Kim2, Y. Kim2, K. Han3, Y. Kim2, H. Lee2

  • Effects of IVIG Therapy and FcγR Polymorphisms on BK Virus Nephropathy in Kidney Transplant Recipients

    D. I. Min1, Y. Chang2, T. Shah3

  • Effects of Major Liver Allocation Policy Changes on Waitlist Outcomes in Multivisceral Transplantation

    S. Nagai1, M. Rizzari1, Y. Muszkat2, K. Collins1, A. Yoshida1, S. Jafri2, M. Abouljoud1

  • Effects of Omega-3 Fatty Acids on Outcome after Living Donor Right Hepatectomy

    S. Lee, J. Kim, G. Choi, J. Joh, S. Lee

  • Effects of Pretreated Bortezomib on Renal Function after Renal Ischemia – Reperfusion Injury in Mice

    X. Zheng

  • Effects of Proton Pump Inhibitors on Allograft Rejection and Adverse Effects in Kidney Transplant Recipients: A Systemic Review and Meta-Analysis

    B. Boonpheng1, C. Thongprayoon2, M. A. Mao3, W. Cheungpasitporn4

  • Effects of Standard Drug Immunosuppression on Peripheral Transitional B Cells and Gene Expression in Non-Human Primates

    A. Bean1, J. Paster1, K. Pruner1, J. O1, W. Sommer2, K. Robinson3, I. Hanekamp1, G. Benichou1, J. Madsen1

  • Effects of Static Subnormothermic Preservation of Extended Warm Ischemic Porcine Kidneys Assessed by Ex-Vivo Machine Perfusion and Renal Transplant Model

    H. Sahara, Y. Ariyoshi, M. Sekijima, T. Iwanaga, A. Shimizu, K. Yamada

  • Effects of Statin Use on Cardiovascular Outcome in Patients with Renal Transplantation

    J. Kim1, K. Park1, S. Park1, M. Yu2, Y. Kim1, K. Kim1, M. Park3, H. Lee1

  • Effects of Thalidomide and Dexamethasone Co-Treatment on CD8+ T Cells

    J. Kim1, E. Kim2, Y. Cho1, H. Lee1, M. Kim3, Y. Kim3, K. Huh3, B. Kim4

  • Efficacious Home Processing of Urine for Messenger RNA Profiling: A Point-of-Care Approach for Molecular Monitoring of Kidney Transplant Recipients

    C. Snopkowski1, C. Li1, S. Albakry1, B. Botticelli1, M. Cassidy1, J. Lee1, M. Lubetzky1, D. Dadhania1, H. Yang1, R. Ding1, T. Muthukumar1, M. Suthanthiran2

  • Efficacy and Safety of Alemtuzumab versus Basiliximab Induction in Lung Transplantation

    J. Choe, J. Au, A. Diamond, C. Ruggia-Check, S. Sehgal, F. Cordova, N. Shigemura, S. Keshavamurthy, Y. Toyoda

  • Efficacy and Safety of Everolimus in Pediatric Renal Transplantation

    T. Sandes-Freitas1, B. Pantoja2, M. Custódio2, A. Goersch Silva3, R. Costa2, M. Sales3, R. Esmeraldo3

  • Efficacy And Safety Of Febuxostat In Renal Transplant Recipients With Hyperuricemia

    L. Liu1, J. Jiang1, Q. Fu2, S. Long3, H. Zhang2, X. Su2, J. Li2, C. Wu2, R. Deng2, W. Zhang3, C. Wang2

  • Efficacy and Safety Outcomes with De Novo Use of Everolimus-Based Regimen in Renal Transplant Recipients with Delayed Graft Function from the TRANSFORM Study

    S. Chadban1, F. Oppenheimer1, F. Citterio1, O. Witzke1, V. D. Garcia1, A. Gutierrez-Dalmau1, P. Narvekar2, M. P. Hernandez Gutierrez2, P. Bernhardt2, A. Wiseman1

  • Efficacy and Safety with Empagliflozin in Renal Transplant Recipients with Post-Transplant Diabetes Mellitus

    K. E. Kvitne1, T. S. Halden2, A. Åsberg2, K. Midtvedt2, A. Hartmann2, T. Jenssen2

  • Efficacy of Belatacept Conversion Protocols

    M. Yazdi, J. Kahwaji, S. Meguerditchian, R. Lee

  • Efficacy of Filgrastim in Solid Organ Transplant Recipients

    M. Spinner1, K. Gaffney1, S. Gundling2

  • Efficacy of Long-Acting Octreotide in Left Ventricular Assist Device Patients with Recurrent Gastrointestinal Bleeding

    T. Wilson1, D. Baran2, J. Herre2, C. Cameron1, W. Old3, G. Zeevi2, C. Barreiro4, C. Kemp4, J. Philpott4, A. Ingemi5

  • Efficacy of Photobiomodulatory Therapy Combined with Short-Term Immunosuppressants Prolonged Allograft Survival in a Rodent Hind-Limb Model

    Y. KUO1, Y. Li1, C. Chen1, R. Chen11, G. Brandacher2

  • Efficacy Of Rituximab Monotherapy On Anti-human Leukocyte Antigen Antibodies In Highly Sensitized Living Donor Kidney Transplant Patients.

    D. J. Sindi1, A. Al Jedai2, H. Aleid3, J. Brockmann4, M. Al-Awwami5, D. Alissa2, E. De Vol6, H. Al Khabbaz7, L. Fajji8

  • Eight-Year Outcomes Following ABO-Incompatible Kidney Transplantation Performed after Desensitization by Antigen-Unspecific Immunoadsorption Devices

    C. Speer1, F. Kälble1, L. Pego da Silva1, C. Nusshag1, M. Schaier1, C. Süsal2, C. Sommerer1, M. Zeier1, C. Morath1

  • Elevated Donor Derived Cell Free DNA (dd-cfDNA) Levels in the Presence of Donor Specific Antibodies (DSA) Are a Strong Predictor of Antibody Mediated Rejection (ABMR) in Pediatric Renal Transplant Recipients

    D. Puliyanda1, R. D. Swinford2, H. Pizzo1, J. Garrison1, I. Kim1, A. M. De Golovine2, S. Jordan1

  • Elevated Podocyte-specific Urinary Extracellular Vesicles In Patients With Fsgs Recurrence After Kidney Transplantation

    H. Lau, A. Shimomura, E. Tantisattamo, U. G. Reddy, D. Dafoe, H. Ichii

  • Elevated Urinary Injury Biomarkers in Deceased Donors Are Not Associated with Long-Term Kidney Transplant Outcomes

    N. Koyawala, I. E. Hall, Y. Jia, S. G. Mansour, P. P. Reese, H. R. Thiessen-Philbrook, E. Akalin, J. S. Bromberg, M. D. Doshi, M. N. Harhay, S. Mohan, T. Muthukumar, B. Schroppel, P. Singh, F. L. Weng, C. R. Parikh

  • Elevated Visceral Adiposity is Associated with Post-Liver Transplant Mortality and Poorly Correlates with BMI in a Prospective Cohort Study

    R. Sharma, R. Rosenblatt, R. Knotts, J. Pisa, E. Verna

  • Emergence of Anti-HLA Antibodies after Catch-Up Vaccinations in Pediatric Kidney Transplant Candidates

    H. Sweiss1, J. Lyons1, D. Ranch2, K. Hitchman2, E. Kincaide1, B. Crowther1

  • En Bloc Kidney Transplant from Infant Donors Less Than 5kg into Adult Recipients

    Z. Wang, Q. Xia, M. Wang, H. Li, J. Liu, J. Liu, J. Liu

  • Endogenous Erythropoietin is Required for Spontaneous Acceptance of Murine Renal Allografts

    J. Horwitz, P. Cravedi, P. Heeger

  • Endothelial Cell Cytoskeleton Rearrangement (ECCSKR) and Endothelial to Mesenchymal Transition (EndoMT) in Liver Allografts Following Acute Rejection (AR): Its Significance on the Development of Liver Fibrosis (LF) and Graft Survival

    B. H. Ozdemir1, G. Ozgun1, E. H. Ayvazoglu Soy2, N. Haberal1, G. Moray2, M. Haberal2

  • Endothelial Cell Replacement – A Closer Step to Personalized, Tissue-Engineered Transplants

    S. Cohen, S. Partouche, M. Gurevich, V. Mezhybovsky, V. Tennak, S. Eisner, E. Nesher, E. Mor

  • Endothelial Cells Do Not Regulate Expression of CD46, CD55 and CD59 in the Presence of Anti-HLA Class I and 11 Antibodies

    A. Babu1, T. Pham2, M. Hamdorf2, V. Jucaud2, M. Everly2, S. Daga3, D. Mitchell4

  • Endovascular Repair Of Abdominal Aortic Aneurysms In Kidney Transplant Recipients

    S. Kwon1, D. Jung1, Y. Kim1, S. Park2, S. Yoon2

  • Engaging Friends and Family in the Care of the Kidney Transplant Candidate: Identifying Needs and Barriers

    A. Hart1, M. Bruin2, M. Partin3, A. Matas4, A. Israni1

  • Engineering Regulatory T Cells With TCR-Signaling-Responsive Interleukin 2 Nanoparticles Provides In Situ Suppression Of Alloimmunity

    S. K. Eskandari1, M. B. Melo2, I. Sulkaj1, N. Li2, S. Cai1, H. Allos1, J. Y. Choi1, D. J. Irvine2, J. R. Azzi1

  • Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living Donor Kidney Transplantation

    R. D. Reed1, V. Kumar1, B. Berry1, D. Hendricks1, A. Carter1, B. A. Shelton1, M. N. Mustian1, P. A. MacLennan1, H. Qu1, L. Hannon2, C. Yates2, M. J. Hanaway1, J. E. Locke1

  • Enhanced Recovery after Surgery Protocols in Kidney Transplantation: Time to Change Practice?

    A. M. Elsabbagh, I. Ghoneim, A. Moiz, D. Mckenney, M. A. Zawaideh

  • Epidemiology and Outcomes of BKV Nephropathy Management by Screening Policy in a Real-Life Setting

    V. D. GARCIA1, F. V. Raupp1, G. MEINERZ1, K. Piegas2, E. KEITEL1

  • Epidemiology and Risk Factors of Early Post-Transplant Clostridium difficile Infection in Renal Transplant Recipients

    M. Jorgenson1, J. Descourouez1, D. Yang2, G. Leverson2, C. Saddler2, J. Smith2, R. Redfield2

  • Epidemiology of Parvovirus B19 and Anemia among Kidney Transplant Recipients

    N. Khoury1, C. Thongprayoon2, N. Leeaphorn3, J. Bruminhent4, W. Cheungpasitporn5

  • Epithelial to Mesenchymal Transition: A Cellular Mediator of Ischemic Cholangiopathy after Liver Transplant

    N. A. Wickramaratne1, R. Li2, R. C. Fyffe-Freil2, T. Tian2, M. J. Mangino2

  • Epitop Matching Predicts Immunization in Kidney Transplant Recipients with Allograft Failure Leading to Worse Outcomes

    F. Halleck1, M. Merkel1, P. Bach2, D. Schmidt1, M. Niemann3, N. Lachmann4, K. Budde1

  • Epitope-Based Matching in Pediatric Kidney Transplantation

    C. Boussard1, M. Ould Rabah2, O. Boyer2, M. Macher1, J. Taupin3, J. Hogan4

  • Epstein Barr Virus (EBV)-Specific T Cells as a Diagnostic Marker for the Individual EBV-Specific Immune Response after Pediatric Kidney Transplantation

    T. Ahlenstiel-Grunow, L. Pape

  • Epstein Barr Virus DNA Integration in B Cell Lymphomas of Post-Transplant Lymphoproliferative Disorder

    M. C. McPherson, O. M. Martinez

  • Erk-elk1-mir-711 Signalling In Cardiac Ischemia Reperfusion Injury In Heart Transplantation

    H. Zheng, Y. Su, C. Zhu, V. Veramkovich, X. Zheng

  • Erythropoietin Ameliorates Parent to F1 Murine Graft versus Host Disease by Inhibiting TFH

    A. Angeletti1, C. Donadei1, A. Cumpelik1, C. Cantarelli1, C. Guglielmo1, G. La Manna2, P. Heeger1, P. Cravedi1

  • Estimated Glomerular Filtration Rate at Donor Screening to Predict Measured Glomerular Filtration Rate after Living Kidney Donation

    J. van der Weijden, M. van Londen, M. Y. Said, S. J. Bakker, S. P. Berger, G. Navis, M. H. de Borst

  • Estimated Post Transplant Survival Allocation: Not Just Better Kidneys, but Faster Ones as Well

    L. Ormiston1, G. Vranic2, J. Moore2, B. Thomas2, M. Cooper2, A. Gilbert2

  • Estimated vs. Actual Graft Failure and Patient Survival after Kidney Transplantation

    J. Buggs1, T. Thigpen2, E. Rogers1, A. Kumar3, V. Bowers1

  • Estrogen Mediated Protection in Renal Ischemia Reperfusion Injury (IRI) is Extrinsic to the Kidney

    D. D. Aufhauser1, S. J. Concors1, P. T. Hernandez1, Z. Wang1, L. Krumeich1, D. R. Murken1, G. Ge1, W. W. Hancock2, M. H. Levine1

  • Etiology of Liver Disease Affects Weight Gain after Liver Transplant

    A. Chandrakumaran1, M. B. Siddiqui2, S. Patel2, F. Lin3, J. Laurenzano2, J. Clinton2, T. Reichman4, C. Bhati4, M. S. Siddiqui2

  • Eupatilin Ameliorates Tacrolimus Induced Nephrotoxicity via Inhibiting Apoptosis

    H. J. Jang, C. S. Park, M. Y. Oh

  • Evaluating Adherence to Immunosuppressive Drugs through Trackyourmed® an Innovative Qr Code-Scanner App in Renal Transplantation: Preliminary Results from i-COM Trial

    E. Melilli1, M. Meneghini1, N. Montero1, A. Coloma1, I. Revuelta2, F. Moreso3, V. Torregrosa2, J. Grinyo1, O. Bestard1

  • Evaluating Allo-Specific CD57+ T Cells during Memory and Proliferative Responses

    A. Lucander, H. Xu, A. Kirk

  • Evaluating Hepatitis C Treatment after Solid Organ Transplantation

    A. J. Burgos1, R. Yau1, C. Tunwar2, J. A. Goss3, S. Khaderi3, N. L. Sussman4

  • Evaluating Liver Regeneration during Normothermic Machine Perfusion in Hepatectomized Rat Liver Model

    M. Aburawi1, S. Mert1, E. Hafiz2, P. Mahboub1, H. Yeh1, K. Uygun1, J. Markmann1

  • Evaluating Potentially Inappropriate Prescribing in Older Kidney Transplant Recipients

    L. DeVietro1, B. Richardson2, E. A. Cohen3, A. H. Toledo4, E. Marin5, K. R. Szempruch6

  • Evaluating the Predictive Utility of the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) for Post-Transplant Outcomes in Moderate to High-Risk Liver Transplant Candidates

    P. Sheiner, S. Spence, D. Gleason, J. Riley, M. Einstein, E. UrtasunSotil, C. Rochon, B. Maneckshana, O. Serrano

  • Evaluation of an Invasive Fungal Infection Prophylaxis Strategy after Liver Transplantation at a Large Academic Medical Center

    M. Jorgenson1, J. Descourouez1, D. Felix1, N. Marka2, G. Leverson2, J. Smith2, L. Fernandez2, D. Foley2

  • Evaluation Of BK Polyomavirus Monitoring And Management In Kidney Transplant Recipients

    M. Tomeczkowicz, S. Mondal, N. Sulejmani, B. Summers, T. Larson, A. Jantz

  • Evaluation Of Complement-related Factors In Tma Post-kidney Transplantation: A Retrospective Multicenter Study

    N. Fujiyama1, M. Tasaki2, H. Harada3, K. Tsutahara4, A. Matsumoto5, Y. Hara6, M. Okumi7, K. Saito2, Y. Watarai8, N. Inoue9, N. Wakamiya9, S. Satoh1

  • Evaluation of Delayed Renal Allograft Function after DCD with New Biomarkers in Donor Blood

    X. Zheng

  • Evaluation of Envarsus XR in African American Kidney Transplant Recipients

    L. R. Lineberger1, E. Hollinger2, N. Kenyon1, M. Brokohf1, N. Alvey1

  • Evaluation of Induction Immunosuppression in Elderly Kidney Transplant Recipients

    C. Pham, S. Kuten, A. Rogers, R. Knight, D. T. Nguyen, E. Graviss, A. Gaber

  • Evaluation of Infection and Renal Transplant Outcomes in the Hmong Population

    M. Jorgenson1, J. Descourouez1, D. Yang2, G. Leverson2, J. Smith2, R. Redfield2

  • Evaluation of Influenza Virus Antibody Response in Naturally Infected and Vaccinated Transplant Recipients by Protein Microarray

    C. Hirzel, A. Chruscinski, V. H. Ferreira, A. G. L'Huillier, A. Humar, D. Kumar

  • Evaluation of Liver Function and Biomarkers Predicts Tumor Progression in Treatment-Naïve Hepatocellular Carinoma Patients

    K. Nunez, T. Sandow, S. Robertson, P. Thevenot, A. Cohen

  • Evaluation of Liver Transplantation among Advanced Age Recipients in a Large Multicenter U.S. Cohort

    A. Goel1, A. Kwong2, D. Devuni3, C. Wang2, J. Boike4, J. Jo4, L. VanWagner4, M. Serper5, L. Jones5, R. Sharma6, E. Verna6, J. Shor3, M. German7, A. Hristov7, A. Lee7, E. Spengler7, A. Koteish8, G. Sehmbey9, A. Seetharam9, N. John1, Y. Patel10, M. Kappus10, T. Couri11, R. Salgia12, Q. Nhu13, C. Frenette13, J. Lai2

  • Evaluation of Medication Burden in Kidney Transplant Recipients at Time of Index Hospitalization

    J. Hardcopf1, H. Meadows1, T. Harrison1, H. Corbo1, B. O'brien1, J. N. Fleming1, C. Perez1, N. Patel1, N. Pilch1, P. K. Baliga2, D. DuBay2, D. Taber1

  • Evaluation of Mycophenolate Mofetil Exposure in Renal Transplant Recipients

    M. C. Ott1, S. Mietz2, S. Chang3

  • Evaluation of New Baskent University Preservation Solution for Liver, Kidney and Intestine Graft during Cold Ischemia: Preliminary Experimental Animal Study

    M. Haberal1, M. Kirnap1, R. Erdem2, H. Ozdemir3, M. Lux2, D. Bacanli4

  • Evaluation of Pneumocystis jirovecii Pneumonia Prophylaxis among Kidney and Liver Transplant Recipients; Trimethoprim/Sulfamethoxazole vs Alternative Therapies

    E. Aldag, C. Pagels, R. Pedersen, I. Nadeem, V. Gunabushanam, A. Sahajpal, T. J. Dilworth

  • Evaluation of Pretransplant Biopsy as a Influence Factor of Early Graft Function after Donated Kidney Transplantation

    X. Qiuxiang, W. Zhendi

  • Evaluation of the Safety and Tolerability of Clazakizumab® (Anti-IL-6 Monoclonal) as a Desensitization Agent in Highly-HLA Sensitized ESRD Patients (nct03380962)

    A. A. Vo, N. Ammerman, E. Huang, A. Peng, R. Najjar, S. Sethi, S. Williamsons, C. Myers, K. Lim, J. Choi, S. C. Jordan

  • Evaluation Of Workplace Environment In Transplant Medicine: Harassment Should Not Be The “Reality Of Life”

    M. Reilly1, T. Branstool1, S. Gregory1, T. R. Pearson2, T. S. Purnell3, G. Gunasekaran4, B. Kelly5, P. N. Martins6, C. M. Mobley7, S. M. Black8, E. C. Maynard9, D. C. Simpson10, M. B. Shah11, O. Ekwenna1, J. Locke12, J. Ortiz1

  • Everolimus/Low Tacrolimus Exposure versus Sodium Mycophenolate/Standard Tacrolimus for the Elderly Kidney Transplant Recipient. A 4-y Follow-Up of the nEverOld Trial

    E. David-Neto, F. Agena, F. J. Paula, N. Z. Galante, D. S. David, F. Ramos, A. K. Triboni, P. Romano, P. A. Ebner, V. Coelho, M. Altona, R. Falci, A. Piovesan, W. C. Nahas

  • Evidence to Support the Use of Kidney Allograft Function as a Clinical Trial Outcome Measure

    M. Kadatz, J. Gill, S. Clark, J. S. Gill

  • Evolution of HHV6- and CMV-Specific T Cell Functional Responses and Immune Cell Populations after Kidney Transplant

    A. Gil1, M. Co2, M. Calvo-Calle1, J. Cruz1, L. Stern1, L. Gibson2

  • Evolution Of Right Laparoscopic Nephrectomy, Report Of A Tertiary Care Center In Mexico

    L. Noriega- Salas, J. Cruz-Santiago, M. Quiñones-Gamero, J. Barcena, M. De Gante, G. Bernaldez-Gomez

  • Ex Vivo Assessment of Marginal Human Kidneys Using Computed Tomography

    M. K. Harris1, J. R. DiRito2, H. Liu3, N. Boutagy3, C. Liu4, S. Hosgood2, D. Mulligan1, M. L. Nicholson2, A. Sinusas3, D. Haakinson1, G. T. Tietjen1

  • Ex Vivo Normothermic Perfusion Of Discarded Human Kidneys Reveals Cold-storage-induced Renal Fibrinogen And Provides A Platform For Therapeutic Repair

    J. DiRito1, S. A. Hosgood2, M. Reschke3, M. L. Nicholson2, G. T. Tietjen4

  • Ex Vivo Resection And Autologous Liver Transplantation As Management Concept For Extensive Malignancy

    K. Bruestle1, A. Griesemer2, S. Lobritto2, M. Martinez2, J. Vittorio2, D. Yamashiro2, E. Bacha3, T. Kato2

  • Ex-Vivo Perfusion Mediated Delivery of Rituximab to Clear Latent Epstein-Barr Virus

    T. Ku, M. Cypel, R. V. Ribeiro, V. H. Ferreira, D. Kumar, A. Humar

  • Ex-vivo Xenoperfusion Of Wild Type And Galtko.hcd55 Pig Livers With Human Whole Blood

    D. Detelich, C. Rickert, C. Eymard, C. Carroll, S. Kimura, H. Yeh, J. Markmann

  • Examination of a Novel Immunoregulatory Marker in Kidney and Lung Transplant Recipients

    A. D. Desai1, G. J. Kavalam2, A. Chandraker2, S. Tripathi2

  • Excellent Outcome in African-American (AA), Type 1 and Type 2 Diabetic Recipients after Simultaneous Pancreas and Kidney Transplantation (SPK)

    A. Gruessner, S. Saggi, R. W. Gruessner

  • Excellent Outcomes in Liver Transplantation under Charity Care: An Opportunity to Mitigate Socio-Economic Disparities in Access to Transplantation

    F. Paterno1, J. Rosado1, R. Olivo2, S. Gavzy1, L. Brown1, D. Wilson1, B. Koneru1, N. Pyrsopoulos2, J. V. Guarrera1

  • Excellent Success with Safety and Efficacy of Direct-Acting Anti-Viral HCV Drugs in Kidney Transplant Recipients Using an Evolving Regimen. A Single Institution Experience

    A. Sharfuddin, S. A. Hussain, T. Taber, D. Mishler, O. Adebiyi, M. S. Yaqub

  • Exendin-4 for Donor Treatment in a Brain-Death Model of Kidney Transplantation

    H. Yang1, L. Luo1, X. Li1, C. Long1, Y. Shi2, Y. Xiong3, M. Chen4, J. Gao5, H. Li6, Z. Wang6

  • Exercise after Heart Transplantation: What is the Reality?

    A. Velleca, K. Norland, N. Musto, N. Mikhail, H. Barone, G. Jamero, R. J. Levine, S. Dimbil, R. Sharoff, E. Passano, J. A. Kobashigawa

  • Exercise for Solid Organ Transplant Candidates and Recipients: A Joint Position Statement of the Canadian Society of Transplantation (CST) and Canadian Network for Rehabilitation and Exercise for Solid Organ Transplant Optimal Recovery (CAN-RESTORE)

    T. Janaudis-Ferreira1, S. Mathur2, R. Deliva3, N. Howes4, C. Patterson5, A. Räkel6, S. So5, L. Wickerson7, M. White6, Y. Avitzur5, O. Johnston8, N. Heywood9, S. Singh7, S. Holdsworth10

  • Exogenous Erythropoietin Administration Promotes Murine Cardiac Allograft Survival via a Myeloid Cell-Dependent Mechanism

    J. Horwitz, P. Cravedi, P. Heeger

  • Exosomes Carry Stress and Damage Specific miRNAs during Peritransplant Period in TPIAT

    P. Saravanan1, M. Kanak1, S. Vasu2, M. Lawrence2, M. Levy1, B. Naziruddin3

  • Exosomes Isolated from Human Lung Transplant Recipients Diagnosed with Bronchiolitis obliterans Syndrome are Unique in Their Ability to Induce IL-6 via Rab27A Signaling Pathway

    M. Rahman, M. Sharma, S. Angara, M. Smith, R. Bremner, T. Mohanakumar

  • Expanding the Donor Pool with Extended Criteria DCD Livers

    P. Mihaylov1, B. Ekser2, R. Mangus2, J. Fridell2, D. Soma2, C. Kubal2

  • Expansion of Myeloid Derived Suppressor Cells Following Alum Administration

    A. G. Cuenca, N. J. Feeney, K. Deng, C. G. Rickert, J. F. Markmann

  • Expansion of Regulatory T and B Cells in Swine Rendered Tolerant of Allogeneic Vascularized Composite Allografts via Mixed Chimerism

    G. Saviane1, A. Lellouch1, A. Andrews1, L. Lantieri2, M. Randolph1, G. Benichou1, C. Cetrulo Jr1

  • Expansion Of The Use Of Left Lobe Grafts In Adult Liver Transplantation In The United States: Different Strategy Between Deceased And Living Donor Grafts

    M. Fujiki, H. Matsushima, K. Sasaki, C. Quintini, F. Aucejo, T. Diago, B. Eghtesad, C. Miller, K. Hashimoto

  • Experience With Letermovir Use For The Management Of Cytomegalovirus In Solid Organ Transplant Recipients

    J. L. Orejas1, F. M. Marty1, A. M. McDonnell2, M. P. Cheng1, E. Arbona-Haddad1, S. P. Hammond1, S. Koo1

  • Exploration of the Stanford Integrated Psychosocial Assessment for Transplant with Psychosocial and Medical Outcomes in Kidney/Kidney-Pancreas Transplant Recipients

    G. Chen1, C. Bell2, P. Loughhead1, B. Ibeche2, J. S. Bynon2, D. R. Hall2, A. M. De Golovine2, A. Edwards2, W. A. Dar2

  • Exploring Perceptions of Organ Procurement: Need for a Formal Medical Student Curriculum

    L. Winer1, M. Vivero2, B. Scully3, A. Cortez1, A. Kassam1, J. Kuethe1, R. Nowygrod3, J. Emond3, R. C. Quillin III1

  • Exploring the Drivers of the Early Decline in One-Year Patient Survival after KAS

    K. Lindblad, A. Wilk, D. Stewart

  • Expression of Prostaglandin E2 Receptors Track with Rejection in Porcine Kidney Transplants

    A. Harner1, Y. Wang2, X. Fang2, R. Lassiter1, T. D. Merchen1, S. Ho3, S. Nahman Jr2

  • External Validation of Donor-Derived Cell-Free DNA to Detect Rejection in Kidney Transplant Recipients

    E. Huang, S. Sethi, A. Peng, R. Najjar, A. Vo, S. Jordan

  • External Validation of the DCD-N Score and a Linear Prediction Model to Identify Potential Candidates for Donation after Circulatory Death: A Nation-Wide Cohort Study

    M. F. Nijhoff1, R. A. Pol1, M. Volbeda1, A. M. Kotsopoulos2, J. P. Sonneveld3, J. van Dongen4, W. F. Abdo5, V. Silderhuis6, C. Moers1

  • External Validation of the Living Kidney Donor Profile Index (LKDPI) in the Canadian Kidney Transplant Recipient Population

    M. Shantier1, Y. Li1, M. Ashwin1, O. Famure1, S. K. Singh2

  • Extracellular Vesicles (EV) Mediate Antibody-Independent Tubular Senescence via Cyclin-Dependent Kinase Inhibitors p21/p16 in Antibody-Mediated Rejection (AMR)

    C. Divella1, A. Stasi1, R. Franzin1, F. Sallustio2, C. Curci1, G. Merlotti3, M. Quaglia3, L. Gesualdo1, V. Cantaluppi1, G. Castellano1

  • Extracorporeal Photopheresis for Specific Immune Tolerance Responses in Heart Transplant Recipients

    M. J. Barten1, K. Klaeske2, J. Wittke2, M. Borger2, J. Garbade2, S. Lehmann3, H. Reichenspurner1, M. Dieterlen2

  • Extreme Hyponatremia as a Risk Factor for Early Mortality after Liver Transplantation in the Model for End-Stage Liver Disease-Sodium Period

    H. Mouzaihem, M. Safwan, L. C. Chau, D. Moonka, M. Abouljoud, S. Nagai

  • Extremes of Body Mass Index is Associated with Inferior Renal Allograft Outcomes in Type 2 Diabetic Deceased Donor Renal Transplant Recipients

    A. Brar, A. Gruessner, F. Tedla, R. Gruessner, J. Renz, N. Sumrani, D. John, M. O. Salifu

Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences